We are live on
!
Find out more
DS
DRW Securities Portfolio holdings
AUM
$4.11B
1-Year Est. Return
21.98%
This Fund
S&P 500
This Quarter
Est. Return
-10.41%
1 Year Est. Return
+21.98%
3 Year Est. Return
+96.16%
5 Year Est. Return
+100.81%
10 Year Est. Return
+306.64%
AUM
$903M
AUM Growth
-$17.9M
(-1.9%)
Cap. Flow
-$7.67M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
93.34%
Holding
139
New
30
Increased
24
Reduced
13
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$27.4M |
| 2 |
Gilead Sciences
GILD
|
+$5.66M |
| 3 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$3.97M |
| 4 |
Pfizer
PFE
|
+$3.04M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$2.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$10.2M |
| 2 |
Vanguard Total Bond Market
BND
|
+$8.62M |
| 3 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$5.39M |
| 4 |
BLUE
bluebird bio
BLUE
|
+$3.78M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 96.17% |
| 2 | Financials | 1.46% |
| 3 | Healthcare | 1.33% |
| 4 | Industrials | 0.34% |
| 5 | Technology | 0.24% |
Similar funds
HCM
GCC
BHC
BB
JIM
DWP
PL
FMII
DRW Securities's Q3 2015 Portfolio in Review
As of Q3 2015, DRW Securities held 139 positions worth $903M, down 1.9% from $921M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
DRW Securities's Q3 2015 filing shows 30 new, 24 increased, 13 reduced and 62 closed positions. Its largest new stake was Gilead Sciences: 51,000 shares worth $5.01M. The largest sale was Vertex Pharmaceuticals, an estimated $10.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 94% a quarter earlier, followed by Financials and Healthcare.
- DRW Securities's largest Q3 2015 buy was Gilead Sciences: 51,000 shares worth $5.01M.
- DRW Securities added most to VelocityShares Daily Inverse VIX Short Term ETN in Q3 2015, an estimated $27.4M increase.
- DRW Securities's biggest Q3 2015 reduction was Vanguard Total Bond Market, cutting an estimated $8.62M.
- DRW Securities fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $10.2M.
- DRW Securities's ten largest holdings make up 93% of its $903M portfolio in Q3 2015.
- DRW Securities opened 30 new positions and closed 62 in Q3 2015.
- DRW Securities's portfolio value fell 1.9% quarter-over-quarter to $903M.
Based on DRW Securities's 13F filing for Q3 2015, filed 16 Nov 2015.